The experts found that myeloma cells react with bone marrow stromal cells in a cell-to-cell interaction, resulting in overexpression of OPGL and downregulation of OPG expression in myeloma patients, which is in turn involved in the pathogenesis of MM-induced bone disease (138). This evidence concerns the gene TNFRSF11B and plasma cell myeloma.